The pitches were virtual for ACC’s Third Annual Innovation Challenge, fitting for devices poised to advance solutions in cardiovascular care through digital means. But they were no less competitive and energetic than past challenges held in ACC’s Future Hub during the Annual Scientific Meeting.

Saranas was the winner in the Cardiovascular Disease Prevention category and iPill Dispenser was the winner in the Telehealth and Virtual Visits category of ACC’s Third Annual Innovation Challenge.

Saranas, Inc., developer of the Early Bird® Bleed Monitoring System for the monitoring and early detection of internal bleed complications during endovascular procedures, announced the online publication of two peer-reviewed articles highlighting the system’s accuracy and performance. The publications provide evidence of the Early Bird’s reliability to detect the early onset and progression of bleeding events during endovascular procedures.

Houston’s startup ecosystem has scaled fast and big this year. Houston has more than 3,000 technology startups that bring an innovative approach in their respective field.

Recognized for its ability to avoid pain, scarring, and long recovery times, minimally invasive vascular access procedures (VAP) continues to gain popularity year over year. That said, VAP does have inherent risks, with patients in nearly 20 percent of cases seeing at least some negative impact related to bleeding. Saranas is a Texas-based company that is focused on minimizing these risks by providing early detection and monitoring of internal bleeding complications via bioimpedance measurements.